D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering

D. Boral Capital acted as Sole Bookrunner to Nature’s Miracle Holding Inc. (Nasdaq: NMHI) in connection with its $3.0 Million Underwritten Public Offering

ONTARIO, Calif., Nov. 12, 2024 /PRNewswire/ — Nature’s Miracle Holding Inc. (NASDAQ: NMHI) (“Nature’s Miracle” or the “Company”), today closed its previously announced underwritten public offering of (a) 25,133,631 units (the “Units”), with each Unit consisting of (i) one share of common stock, par value $0.0001 per share (the “Common Stock”), (ii) one Series A… Continue reading D. Boral Capital acted as Sole Bookrunner to Nature’s Miracle Holding Inc. (Nasdaq: NMHI) in connection with its $3.0 Million Underwritten Public Offering

D. Boral Capital acted as Co-Underwriter to Aduro Clean Technologies Inc. (Nasdaq: ADUR) in Connection with its $4.0 Million Uplisting to Nasdaq

London, Ontario – November 8, 2024, (GLOBE NEWSWIRE) – Aduro Clean Technologies Inc. (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5) (“Aduro” or the “Company”), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the closing… Continue reading D. Boral Capital acted as Co-Underwriter to Aduro Clean Technologies Inc. (Nasdaq: ADUR) in Connection with its $4.0 Million Uplisting to Nasdaq

D. Boral Capital Celebrates Exceptional Performance in 2024

  D. Boral Capital, a premier investment bank focused on high-quality mid-market and growth issuers, has concluded an outstanding year in 2024, solidifying its position as a leader in the financial services industry. The firm’s impressive performance is reflected in its comprehensive transaction portfolio, showcasing its expertise across various sectors and transaction types. In 2024,… Continue reading D. Boral Capital Celebrates Exceptional Performance in 2024